Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07113847Phase 3Active, not recruiting
Phase 3, randomised, open-label trial in dentin hypersensitivity (DH) (4 arms), sponsored by The British University in Egypt. Primary endpoint: Visual Analogue Scale Pain Score at 6 months. Started Apr 2025; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07113847.